Clinical Report: Researchers Propose TMD Definition for GBD

Overview

A new consensus-based lay description for temporomandibular disorders (TMDs) has been developed to improve their representation in Global Burden of Disease (GBD) estimates. This effort aims to address the significant impact of TMDs on quality of life and disability, which has been overlooked in current health metrics.

Background

Temporomandibular disorders (TMDs) affect approximately 5-12% of adults globally, leading to pain and impaired oral function. Despite their prevalence, TMDs have not been adequately represented in Global Burden of Disease measures, which currently focus on other oral health conditions. The absence of standardized lay descriptions has hindered the calculation of disability weights, essential for accurate disease burden estimation.

Data Highlights

The consensus process generated 718 descriptive terms, refined to 231 unique terms categorized into symptom description, pain location, consequences, and impact.

Key Findings

• The proposed lay description for TMDs includes pain in the jaw, face, cheeks, or around the ears, with varying characteristics.
• Severity of TMDs is categorized as mild, moderate, or severe based on pain duration, intensity, and frequency.
• Prior GBD analyses have shown that revising lay descriptions can significantly alter disability weights.
• The consensus process involved international clinicians, researchers, and patient representatives, though it may not fully represent all perspectives.
• Accurate lay descriptions are crucial for estimating disability weights and understanding the true burden of TMDs.

Clinical Implications

Healthcare professionals should be aware of the new lay description for TMDs as it may influence future assessments of disease burden and treatment approaches. Incorporating patient perspectives in future studies will enhance the relevance and accuracy of TMD management strategies.

Conclusion

The development of a standardized lay description for TMDs marks a significant step towards their inclusion in GBD estimates, highlighting the need for ongoing research and patient involvement in defining health conditions.

References

1. BMC Medicine, 2023 -- Researchers Propose TMD Definition for GBD
2. Journal of Gastroenterology — Epidemiology and Real-World Application of Biologic Treatments for Behçet’s Disease in Japan
3. Contact Lens Spectrum — Meibomian Gland Dysfunction: An Update
4. Optometric Management — A Deeper Understanding of MGD
5. Ophthalmology Management — Beyond the Meibomian Glands
6. Epidemiology and Real-World Application of Biologic Treatments for Behçet’s Disease in Japan
7. Meibomian Gland Dysfunction: An Update
8. A Deeper Understanding of MGD
9. Oral disordersThis document describes the non-fatal disease burden modelling process for GBD 2021 for each of edentulism, caries of deciduous teeth, caries of permanent teeth, chronic periodontal disease, and other oral disorders.Input dataData seeking and systematic literature reviews were completed for all oral disorders together, given the
10. Temporomandibular disorders: A new list of key points to summarize the standard of care - PMC
11. The efficacy of treatments for temporomandibular disorders with occlusal splints versus other conservative therapies: a meta-analysis of randomized controlled trials - PubMed